These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30223078)

  • 21. Insights on the Physical State Reached by an Active Pharmaceutical Ingredient upon High-Energy Milling.
    Schammé B; Monnier X; Couvrat N; Delbreilh L; Dupray V; Dargent É; Coquerel G
    J Phys Chem B; 2017 May; 121(19):5142-5150. PubMed ID: 28430440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of milling and compression on the solid-state Maillard reaction.
    Qiu Z; Stowell JG; Cao W; Morris KR; Byrn SR; Carvajal MT
    J Pharm Sci; 2005 Nov; 94(11):2568-80. PubMed ID: 16200560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
    Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
    Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solid state amorphization kinetic of alpha lactose upon mechanical milling.
    Caron V; Willart JF; Lefort R; Derollez P; Danède F; Descamps M
    Carbohydr Res; 2011 Nov; 346(16):2622-8. PubMed ID: 21983262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical stability of redispersible dry emulsions containing amorphous sucrose.
    Christensen KL; Pedersen GP; Kristensen HG
    Eur J Pharm Biopharm; 2002 Mar; 53(2):147-53. PubMed ID: 11879996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formation of physically stable amorphous drugs by milling with Neusilin.
    Gupta MK; Vanwert A; Bogner RH
    J Pharm Sci; 2003 Mar; 92(3):536-51. PubMed ID: 12587115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of phase composition and nanoscale microstructure of high-energy ball-milled MgCu sample.
    Ma Z; Liu Y; Yu L; Cai Q
    Nanoscale Res Lett; 2012 Jul; 7(1):390. PubMed ID: 22793264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
    Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
    Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relaxation dynamics and crystallization study of sildenafil in the liquid and glassy states.
    Kolodziejczyk K; Paluch M; Grzybowska K; Grzybowski A; Wojnarowska Z; Hawelek L; Ziolo JD
    Mol Pharm; 2013 Jun; 10(6):2270-82. PubMed ID: 23594226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of physical properties and stability of indomethacin-cimetidine and naproxen-cimetidine co-amorphous systems prepared by quench cooling, coprecipitation and ball milling.
    Lim AW; Löbmann K; Grohganz H; Rades T; Chieng N
    J Pharm Pharmacol; 2016 Jan; 68(1):36-45. PubMed ID: 26663364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dynamics, physical stability and solubility advantage from amorphous indapamide drug.
    Wojnarowska Z; Grzybowska K; Hawelek L; Dulski M; Wrzalik R; Gruszka I; Paluch M; Pienkowska K; Sawicki W; Bujak P; Paluch KJ; Tajber L; Markowski J
    Mol Pharm; 2013 Oct; 10(10):3612-27. PubMed ID: 24070615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives.
    Balani PN; Ng WK; Tan RB; Chan SY
    J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sucrose/Glucose molecular alloys by cryomilling.
    Megarry AJ; Booth J; Burley J
    J Pharm Sci; 2014 Jul; 103(7):2098-2106. PubMed ID: 24867316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FTIR study of state and phase transitions of low moisture sucrose and lactose.
    Ottenhof MA; MacNaughtan W; Farhat IA
    Carbohydr Res; 2003 Oct; 338(21):2195-202. PubMed ID: 14553980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of amorphous content on compaction behaviour of anhydrous alpha-lactose.
    Ziffels S; Steckel H
    Int J Pharm; 2010 Mar; 387(1-2):71-8. PubMed ID: 20005927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of amorphous content in the pharmaceutical process environment.
    Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of inverse phase gas chromatography to study the change of surface energy of amorphous lactose as a function of relative humidity and the processes of collapse and crystallisation.
    Newell HE; Buckton G; Butler DA; Thielmann F; Williams DR
    Int J Pharm; 2001 Apr; 217(1-2):45-56. PubMed ID: 11292541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.